Ryan Abbott, M.D., Esq., FCIArb has extensive domestic and international experience in the fields of intellectual property and health care, and offers unique expertise in such matters as biologics, pharmaceuticals, medical devices, medical and life sciences, computer technology and distributed ledger technology. Dr. Abbott divides his time between Los Angeles, California and London, England.
Dr. Abbott has served as partner at a litigation firm, general counsel of a biotechnology company and of counsel at a firm specializing in transactional matters and intellectual property litigation for life science companies. In these capacities, he has substantial ADR experience as outside and inside counsel for both claimants and respondents. He has also worked as an expert for the European Commission, the World Intellectual Property Organization (WIPO) and the World Health Organization (WHO). Dr. Abbott lectures frequently on issues related to artificial intelligence, biotechnology, and information and communication technologies.
Dr. Abbott is a licensed physician and patent attorney in the United States (California and New York) and a solicitor (non-practicing) in England and Wales. He is board certified by the American Board of Legal Medicine. In addition to serving as a JAMS neutral, he is a WIPO, IACT, and United Kingdom Intellectual Property Office (UKIPO) panelist, a CEDR-accredited mediator and a Fellow of the Chartered Institute of Arbitrators (FCIArb). He has a reputation for rigorous preparation, engagement and adaptability.
Dr. Abbott is professor of law and health sciences at the University of Surrey School of Law and adjunct assistant professor of medicine at the David Geffen School of Medicine at UCLA. He is a graduate of the University of California San Diego School of Medicine and Yale Law School.